Pharmacoeconomics--determination of the cost-effectiveness of Helicobacter pylori eradication.
Curtiss
Frederic R
FR
D003362:Cost-Benefit Analysis; D003661:Decision Support Techniques; D017850:Economics, Pharmaceutical; D016481:Helicobacter Infections / Q000188:drug therapy* / Q000191:economics; D016480:Helicobacter pylori; D006801:Humans